Quantified
APRIL 18, 2022
A global head of sales at a pharma company recently told me that “only 15% of our sales calls end in a positive outcome.”. Why is success in pharma sales so hard? Pharma has always been highly restrictive in terms of the different tools you can use to engage, educate and inform about prescription medicines.
Clarity Engagement Solutions
NOVEMBER 9, 2020
Traditionally the pharma industry relied on the volume of prescriptions made. A primary challenge for pharma and bio-tech companies is how to identify the right stakeholders in the approval process. Pharma and bio-tech companies need to adopt more innovative market access tactics to succeed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarity Engagement Solutions
NOVEMBER 9, 2020
Traditionally the pharma industry relied on the volume of prescriptions made. the evolving healthcare industry, pharma and bio-tech companies are now focusing on each component of market access: – Price. A primary challenge for pharma and bio-tech companies is how to identify the right stakeholders in the approval process.
pharmaphorum
DECEMBER 23, 2022
Companies that adopt this blended model will be able to recognise performance gaps earlier and, for the first time, align incentives across the entire commercial ecosystem, including sales reps, key account managers, and medical science liaisons.”. Food and Drug Administration’s Office of Prescription Drug Promotion ( OPDP ).”.
Evolve Your Success
JANUARY 31, 2023
A lot of organizations that may have a sales model don’t probably follow the prescription that we deliver or the method that we deliver to them, which is why they contract us. Number one is if you want to make the transition from pharma to medical device, many people have gone back and forth. We all know what they do.
Expert insights. Personalized for you.
52 
Let's personalize your content